• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Clinical Features and Outcomes of Critically Ill Patients with Coronavirus Disease 2019 (COVID-19): A Multicenter Cohort Study

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2021 Feb 15;S1201-9712(21)00123-5.
doi: 10.1016/j.ijid.2021.02.037. Online ahead of print.
Clinical Features and Outcomes of Critically Ill Patients with Coronavirus Disease 2019 (COVID-19): A Multicenter Cohort Study


Khalid A Al Sulaiman[SUP] 1 [/SUP], Ohoud A Al Juhani[SUP] 2 [/SUP], Khalid Eljaaly[SUP] 2 [/SUP], Aisha A Alharbi[SUP] 3 [/SUP], Adel M Al Shabasy[SUP] 4 [/SUP], Alawi S Alsaeedi[SUP] 5 [/SUP], Mashael Al Mutairi[SUP] 6 [/SUP], Hisham A Badreldin[SUP] 7 [/SUP], Shmeylan A Al Harbi[SUP] 7 [/SUP], Hussain A Al Haji[SUP] 8 [/SUP], Omar I Al Zumai[SUP] 8 [/SUP], Ramesh K Vishwakarma[SUP] 9 [/SUP], Abdulmalik Alkatheri[SUP] 7 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease-19 (COVID-19) manifested by a broad spectrum of symptoms, ranging from asymptomatic manifestations to severe illness and death. The purpose of the study was to extensively describe the clinical features and outcomes in critically ill patients with COVID19 in Saudi Arabia.
Method: A multi-center, non-interventional, cohort study for all critically ill patients aged 18 years or older who are admitted to intensive care units (ICUs) between March 1[SUP]st[/SUP] to August 31[SUP]st[/SUP], 2020 with an objectively confirmed diagnosis of COVID19. The diagnosis of COVID19 was confirmed by Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) on nasopharyngeal and/or throat swabs. Multivariate logistic regression and generalized linear regression were used. We considered a P value of<0.05 statistically significant.
Results: A total of 560 patients met the inclusion criteria. An extensive list of clinical features were associated with higher 30-days ICU mortality rate such as requiring mechanical ventilation (MV) or developing acute kidney injury within 24hours of ICU admission, higher body temperature, white blood cells, blood glucose level, serum creatinine, fibrinogen, procalcitonin, creatine phosphokinase, aspartate aminotransferase and Total iron-binding capacity. The most common complication during ICU stay was respiratory failure that required MV (71.4%), followed by acute kidney injury (AKI) and thrombosis with a proportion of 46.8% and 11.4% respectively.
Conclusion: Among patients with COVID19 who were admitted to the ICU, several variables were associated with increasing the risk of ICU mortality at 30 days. Respiratory failure that required MV, AKI and thrombosis were the most common complications during ICU stay.

Keywords: 30-days ICU mortality; COVID19; Clinical Features; Critically ill; Intensive Care Units (ICUs).
 
Back
Top Bottom